A Population-based Study on the First Forty-Eight Breast Cancer Patients Receiving Trastuzumab (Herceptin®) on a Named Patient Basis in SwedenJ. Andersson, Jonas Bergh, Henrik Lindman et al.|Acta Oncologica|2002Cited by 22
Can Axillary Dissection be Avoided by Improved Molecular Biological Diagnosis?Thomas Lindahl, Jonas Bergh, Georg Engel et al.|Acta Oncologica|2000Cited by 17